Tech Company Financing Transactions
Elevation Oncology Funding Round
Elevation Oncology, based in New York, received $32.5 million from Aisling Capital, BVF Partners and Driehaus Capital Management.
Transaction Overview
Company Name
Announced On
7/22/2020
Transaction Type
Venture Equity
Amount
$32,500,000
Round
Series A
Investors
Aisling Capital (Lead Investor) (Steve Elms)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
888 7th Ave. 12th Floor
New York, NY 10106
USA
New York, NY 10106
USA
Phone
Website
Email Address
Overview
Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. We make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Steve Elms
Chief Executive Officer
Shawn Leland
Vice President
Douglas Plessinger
Vice President
Siera Talbott
VP - Regulatory Affairs
Amy Cavers
VP - Regulatory Affairs
Sheila Magil
Browse more venture capital transactions:
Prev: 7/22/2020: Angle Health venture capital transaction
Next: 7/22/2020: MeetElise venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs